Deubiquitinases: Pro-oncogenic Activity and Therapeutic Targeting in Blood Malignancies.

ABSTRACT: Deubiquitinases are enzymes that remove ubiquitin moieties from the vast majority of cellular proteins, controlling their stability, interactions, and localization. The expression and activity of deubiquitinases are critical for physiology and can go awry in various diseases, including cancer. Based on recent findings in human blood cancers, we discuss the functions of selected deubiquitinases in acute leukemia and efforts to target these enzymes with the aim of blocking leukemia growth and improving disease outcomes. We focus on the emergence of the newest generation of preclinical inhibitors by discussing their modes of inhibition and their effects on leukemia biology.

SUBMITTER: Gutierrez-Diaz BT 

PROVIDER: S-EPMC7258259 | biostudies-literature | 2020 Apr

REPOSITORIES: biostudies-literature